MedPath

?RTMS effects on PSP patients

Not Applicable
Conditions
PSP Proressive supranuclear palsy.
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
G23.1
Registration Number
IRCT20230504058069N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
12
Inclusion Criteria

PSP patients that was diagnosed by national institute of neurologic disease and stroke for PSP citeria
patient who can stand alon and without helping
patient who can walking at least a few steps without helping
patient who can speak and answer the questions
patient who has signed the informed consent form to enter the plan

Exclusion Criteria

patient who was diagnosed dementia by DSM-IV criteria
patient who had vestibular or properioception or sensory deficits
patient who has any contraindication of brain stimulation (such as pacemakers or presence of metal objects in the head)
the patient had dysartheria before the onset of disease
patient who had past medical history of stroke
patient who is mute

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Checking the postural instabilility of patients. Timepoint: The beginning of the study (before starting rTMS), the end of receiving rTMS, four months later. Method of measurement: Kinematic analysis of scoring movement based on the results of forces and energy.;Checking the speech and swalling of patients. Timepoint: The beginning of the study (before starting rTMS), the end of receiving rTMS, four months later. Method of measurement: Wanberg's auditory-perceptual assessment index and the Northwestern swallowing disorder test.
Secondary Outcome Measures
NameTimeMethod
????? ????? ???????. Timepoint: The beginning of the study and the end of the study. Method of measurement: PDQL questionnaire.
© Copyright 2025. All Rights Reserved by MedPath